Rozek Elizabeth 4
4 · Sagimet Biosciences Inc. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
Rozek Elizabeth
Chief Legal & Admin. Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-11-04+13,367→ 13,367 totalExercise: $7.61Exp: 2035-11-03→ Series A Common Stock (13,367 underlying) - Award
Series A Common Stock
2025-11-04+9,855→ 193,581 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's promotion within the Company. Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date.
- [F2]This option was granted in connection with the Reporting Person's promotion within the Company. The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date.